[
  {
    "ts": null,
    "headline": "BMY Reports Positive Data on Sotyktu From Arthritis Study",
    "summary": "Bristol Myers' Sotyktu hits key goals in late-stage PsA trial, fueling hopes for expansion amid recent pipeline setbacks.",
    "url": "https://finnhub.io/api/news?id=5db13f51acd76939591f9df3e3bdff2e54669f9e6928de5cb48528c64db62b60",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749734100,
      "headline": "BMY Reports Positive Data on Sotyktu From Arthritis Study",
      "id": 135218799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers' Sotyktu hits key goals in late-stage PsA trial, fueling hopes for expansion amid recent pipeline setbacks.",
      "url": "https://finnhub.io/api/news?id=5db13f51acd76939591f9df3e3bdff2e54669f9e6928de5cb48528c64db62b60"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
    "summary": "PRINCETON, N.J., June 12, 2025--Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
    "url": "https://finnhub.io/api/news?id=fe7829381d7757ee7ac5555272634798f780784cb2413e9aef246a64fc7fa749",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749725940,
      "headline": "Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
      "id": 135218801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., June 12, 2025--Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
      "url": "https://finnhub.io/api/news?id=fe7829381d7757ee7ac5555272634798f780784cb2413e9aef246a64fc7fa749"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025",
    "summary": "PRINCETON, N.J., June 12, 2025--Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025",
    "url": "https://finnhub.io/api/news?id=c5e8cb0ee95d651e6cb51e87c9d3e77f042d7d59d8c94f4f52646e5a9d42044f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749725100,
      "headline": "Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025",
      "id": 135218804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., June 12, 2025--Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025",
      "url": "https://finnhub.io/api/news?id=c5e8cb0ee95d651e6cb51e87c9d3e77f042d7d59d8c94f4f52646e5a9d42044f"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu Compared with Placebo in Adults with Psoriatic Arthritis",
    "summary": "PRINCETON - Bristol Myers Squibb announced positive data from the pivotal Phase 3 POETYK PsA-1 trial evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis who...",
    "url": "https://finnhub.io/api/news?id=f951809738f2853c41b3e8660c9fff2956f21ea7c3b4f684fb1828724e82d7d2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749723921,
      "headline": "Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu Compared with Placebo in Adults with Psoriatic Arthritis",
      "id": 135212802,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb announced positive data from the pivotal Phase 3 POETYK PsA-1 trial evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis who...",
      "url": "https://finnhub.io/api/news?id=f951809738f2853c41b3e8660c9fff2956f21ea7c3b4f684fb1828724e82d7d2"
    }
  },
  {
    "ts": null,
    "headline": "BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business",
    "summary": "BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business",
    "url": "https://finnhub.io/api/news?id=fbdb71b848674c6e44a59c3a9e61b5f52cfa013a55f81aee8bf628973c90117b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749723600,
      "headline": "BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business",
      "id": 135218423,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business",
      "url": "https://finnhub.io/api/news?id=fbdb71b848674c6e44a59c3a9e61b5f52cfa013a55f81aee8bf628973c90117b"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD? Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
    "summary": "Bristol Myers Squibb announced the presentation of new data from its targeted protein degradation platform during the 2025 European Hematology Association Annual Congress being held from June 12-15...",
    "url": "https://finnhub.io/api/news?id=d8b43eb032ed6e5a923c2a89811686c92119568013e59ed53ae1d2fc4439aad6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749720071,
      "headline": "Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD? Agents and BCL6 Ligand-Directed Degrader at EHA 2025",
      "id": 135212180,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb announced the presentation of new data from its targeted protein degradation platform during the 2025 European Hematology Association Annual Congress being held from June 12-15...",
      "url": "https://finnhub.io/api/news?id=d8b43eb032ed6e5a923c2a89811686c92119568013e59ed53ae1d2fc4439aad6"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Harvesting Portfolio Week 223: $22,300 Allocated, $2,310.77 In Projected Dividends",
    "summary": "The Dividend Harvesting Portfolio hit a new all-time high, delivering a 26.95% return. Learn more about the portfolio here and my recent additions.",
    "url": "https://finnhub.io/api/news?id=c1178388b293665fb6093c6cac8a5fe2e61679f7b3eb87befe791c104b65b6b7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749718800,
      "headline": "Dividend Harvesting Portfolio Week 223: $22,300 Allocated, $2,310.77 In Projected Dividends",
      "id": 135212066,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "The Dividend Harvesting Portfolio hit a new all-time high, delivering a 26.95% return. Learn more about the portfolio here and my recent additions.",
      "url": "https://finnhub.io/api/news?id=c1178388b293665fb6093c6cac8a5fe2e61679f7b3eb87befe791c104b65b6b7"
    }
  },
  {
    "ts": null,
    "headline": "Dogs Of The S&P 500 Fetch 11 June 'Safer' Dividend Buys",
    "summary": "Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more about the dividend dogs here.",
    "url": "https://finnhub.io/api/news?id=25a03981edd57001ec6582bdfab50e555b73e78844d28ddafd0bf1ede7722543",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749700793,
      "headline": "Dogs Of The S&P 500 Fetch 11 June 'Safer' Dividend Buys",
      "id": 135209965,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1997911742/image_1997911742.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more about the dividend dogs here.",
      "url": "https://finnhub.io/api/news?id=25a03981edd57001ec6582bdfab50e555b73e78844d28ddafd0bf1ede7722543"
    }
  }
]